Tolemerase
Tolemerase
Reg. NO - 04052113044
Submitted To – Dr. Asif Jamal
Subject – Molecular Microbiology
Semester – BS 7th
Role of Telomerase in Ageing and Cell Crisis
Introduction
Telomerase is a ribonucleoprotease that is essential for maintaining the structural and functional
integrity of chromosomes. It does this by lengthening telomeres, repetitive nucleotide sequences at
the ends of linear chromosomes that act as protective caps. Telomeres protect chromosomes from
breakage, fusion, and abnormal recombination, ensuring normal cellular function and genome
stability. However, DNA polymerase cannot fully repair the ends of linear DNA, a phenomenon known
as the “end-action problem,” which leads to the gradual shortening of telomeres during cell division.
This shortening of telomeres acts as a molecular clock that limits the replicative capacity of most
somatic cells, culminating in a phenomenon known as relicative senescence. This mechanism
becomes an important antitumor barrier, but it also contributes to cellular aging and tissue failure. On
the other hand, telomerase activity is present in some cell types, such as germ cells, stem cells, and
some immune cells, which can divide for a long time and persist throughout life.
The dual role of telomerase in promoting cell survival and its potential involvement in tumorigenesis
have been the subject of intense research. Currently, telomerase deficiency has been linked to aging
and degenerative diseases. Hyperactivation, on the other hand, is a hallmark of cancer, giving tumor
cells the ability to circumvent replication restrictions and grow out of control. These different effects
demonstrate the complexity of telomerase regulation and its critical importance for cellular
homeostasis.
In recent years, advances in molecular biology and biotechnology have deepened our understanding
of telomerase and demonstrated its potential as a therapeutic target. Researchers are exploring ways
to use telomerase in therapeutic and antiaging therapies, and developing strategies to block its
activity in cancer cells. This multifunctional enzyme plays a key role in the biology of aging and
cellular dysfunction, but also holds promise for solving some of the biggest challenges in modern
medicine.
Telomeres are specialized nucleoprotein structures at the ends of linear chromosomes composed of
repeated nucleotide sequences (TTAGGG in humans) and associated proteins. These structures act
as protective caps, protecting chromosome ends from breakage and ensuring genome stability during
cell division. Telomeres play an important role in cell function and health:
• Protect chromosome ends: Telomeres prevent chromosome ends from being recognized
as DNA breaks by the cell's DNA repair machinery. Without this protection, chromosome
ends may be improperly repaired, leading to chromosomal aberrations and genome
instability.
• Prevents replication termination problem: DNA polymerase, which copies the genome
during cell division, is unable to completely copy the ends of linear DNA. This results in a
gradual loss of terminal order, known as the backscatter problem. Telomeres prevent this
loss by abandoning repetitive sequences in place of critical coding regions of the genome.
• Promotes chromosome segregation: Telomeres and their associated proteins (the
Shelter complex) contribute to the structural integrity and proper segregation of
chromosomes during mitosis.Telomeres are not merely inert chromosomal ends; they are
dynamic structures regulated by the shelterin protein complex.
This complex consists of several proteins, including TRF1, TRF2, POT1, TIN2, TPP1, and RAP1, that
maintain telomere integrity and mediate telomerase entry into telomeric DNA. These proteins
coordinate processes such as:
• Inhibition of DNA damage response: Shelterin prevents the inappropriate activation of
DNA damage response at telomeres, thereby preventing cell cycle arrest or apoptosis.
• Regulation of telomerase activity: Shelterin regulates the entry of telomerase into
telomeres, ensuring that telomere length is tightly regulated and does not exceed the limits
of the body.
Maintaining telomere length is essential for overall health and fitness. In stem and germ cells,
telomerase activity prevents telomere shortening, allowing these cells to maintain their replicative
potential throughout the life of the organism. In contrast, in most somatic cells, the lack of significant
telomerase activity leads to telomere shortening, ultimately leading to senescence or apoptosis.
Telomere dysfunction, whether due to excessive shortening or impaired protective function, has
significant health consequences. Extremely short telomeres are associated with age-related
diseases, including cardiovascular disease, neurodegenerative diseases, and impaired wound
healing. However, abnormal telomere maintenance, as observed in cancer cells, allows for
uncontrolled replication and drives tumorigenesis. The dual role of telomeres in aging and disease
highlights the importance of telomeres as therapeutic targets in both regenerative medicine and
cancer therapy.
Telomerase plays an important role in cell biology by preventing telomere shortening and preventing
cell replication. A ribonucleoprotein complex with two major components:
These fragments allow telomerase to extend beyond the 3' end of telomeric DNA, compensating for
the loss of the sequence during the cell cycle. Telomerase is highly regulated in various cell types
and developmental stages, ensuring optimal cellular function.
• Active in germ cells and stem cells: Telomerase is very active in germ cells, ensuring
genetic protection from generation to generation. In stem cells, telomerase maintains a set
of differentiated cells that can regenerate and differentiate, which is important for
homeostasis and maintenance.
• Low or absent telomerase activity in somatic cells: In most somatic cells, telomerase
activity is low or absent, resulting in slow telomere shortening and a life cycle of continuous
replication. This regulation is an important way to shrink tumors and prevent cells from
dividing for a long time.
Mechanism of Action
The process by which telomerase lengthens telomeres consists of several controlled steps:
1. Binding: Binding of telomerase to a single strand of the 3' end of telomeric DNA.
2. Supplement: Taking TERC as an example, TERT will generate new telomeric repeat
sequences, thereby extending the DNA chain.
3. Translocation: After increased replication, telomerase moves to the new end and repeats the
process to complete the telomere.
This cyclic process restores telomeres, maintains chromosomal stability, and allows cells to continue
dividing in telomerase-positive cells.
Regulation of Telomerase Activity
Physiological Roles
Understanding the role of telomerase in cell biology has important implications for the aging process,
regenerative capacity, and the propagation of diseases such as cancer. It has the positive effect of
preventing uncontrolled cell growth and promoting cell regeneration.
Cell crisis, also known as replication crisis, is an important stage in the life of a cell characterized by
instability and mass death. These conditions usually occur when telomeres are too short, leading to
DNA damage pathways. The role of telomerase in changing the state of the cell is multifaceted, as it
can prevent or increase this state depending on the state of the cell.
The main cause of cell death is telomere attrition, which occurs during repeated cell division when
telomerase activity is insufficient. Shortened telomeres are unable to maintain the protective capping
mechanism, resulting in:
1. Chromosomal end fusion: The DNA repair machinery recognizes unprotected telomeres as
double-stranded, leading to end-to-end fusion and chromosomal instability.
2. DNA damage response: Shortened telomeres activate pathways such as ATM and ATR
kinase signaling, which lead to cell cycle arrest, apoptosis, or senescence.
3. Normal instability: The splice-break-replication cycle leads to aneuploidy and major genetic
rearrangements that result in a highly unstable cellular environment.
Telomerase can slow down the occurrence of cell damage by maintaining telomere length and gene
stability. The main functions are:
• Telomere elongation: By lengthening telomeres that are too short, telomerase prevents
DNA damage and the cell enters the replication cycle.
• Reduces gene loss: Telomerase ensures that telomeres maintain their protective
structure, preventing replication and chromosome breakage.
• Sertoli cell population: In stem and germ cells, telomerase activity is important for
maintaining regenerative capacity and preventing premature death.
While telomerase plays a protective role in normal cells, its uncontrolled activation is a hallmark of
cancer. In oncogenic cells, telomerase restoration allows them to evade cell death, thereby
contributing to immortality and tumorigenesis. These two functions highlight the complexity of
telomerase regulation:
• Escape from senescence: Telomerase reactivation helps cells avoid excessive replication
and continue to divide.
• Promotes malignant transformation: By stabilizing telomeres, telomerase facilitates the
acquisition of other mutations and genetic alterations that contribute to tumorigenesis.
Therapeutic implications
The relationship between telomerase and cellular diseases allows for therapeutic approaches:
The past few years have brought significant advances in understanding the biology of telomerase,
driven by advances in molecular and cellular technologies. These advances have increased our
understanding of telomerase, its function, and its implications for health and disease.
Structural insights
• Facilitates the identification of key factors responsible for its function and substrate binding.
• It has enabled the design of small molecules and inhibitors that target specific regions of
the enzyme for therapeutic purposes.
Mechanistic Discoveries
Advances in biochemistry and genomics reveal new mechanisms of telomerase activity and
regulation:
Clinical Applications
• Anticancer drugs: Telomerase inhibitors (e.g., imetelstat) are in clinical trials for the
treatment of malignant diseases, including myelofibrosis and solid tumors. .
• Regenerative Medicine: Strategies to temporarily activate telomerase in stem cells are
being explored to counteract age-related decline and improve tissue repair.
• Biomarkers: Telomerase activity and telomere length are being investigated as diagnostic
and prognostic biomarkers for cancer, aging, and cardiovascular disease.
Gene editing technology: CRISPR-Cas9 and related tools have revolutionized telomerase research
• Ability to precisely modify TERT and TERC genes, facilitating study of their role in cellular
processes.
• Provides a platform for the development of gene therapies designed to correct telomerase
defects in diseases such as dyskeratosis congenita.
Emerging Concepts
Future Directions
These advances highlight the important role of telomerase in today's biomedical research and raise
hopes for new treatments for aging, cancer, and other telomere diseases.
Conclusion
Telomerase is a key regulator of cell life, balancing the need for tissue renewal and preventing
uncontrolled proliferation. While telomerase deficiency contributes to aging and degenerative
diseases, overexpression of telomerase is a hallmark of cancer. Ongoing research into telomerase
biology holds promise for the development of targeted therapies to address the challenges of aging,
cancer, and regenerative medicine.
Structure and function of telomerase. Mammalian telomeres comprise (TTAGGG) n DNA sequences
and telomerase. Telomerase comprises three major subunits: (1) the RNA template telomerase
component 1 [TLC1 or telomerase RNA component (TERC); (AAUCCC) n ], which provides the
sequence information used by telomerase to direct DNA synthesis; (2) the catalytic protein subunit
[ever shorter telomeres 2 protein (Est2p) in Saccharomyces cerevisiae and telomerase reverse
transcriptase (TERT) in other organisms], which catalyzes the addition of oligonucleotide (TTAGGG)
repeats to telomeres, the repetitive DNA structures residing at the ends of linear chromosomes 106 ;
and (3) the telomerase-associated multiprotein complex known as 'shelterin', which comprises six
factors [telomere restriction fragment (TRF)-1, TRF-2, telomere-associated protein 1 (TPP1),
protector of telomeres 1 (POT1), TRF1-interacting protein 2 (TIN2), and human protein repression
and activation protein 1 (hRap1)] and assures proper telomere length regulation and telomere
protection . 107 kb, kilobase.
Telomerase: The link between aging, cancer, and inflammation. This figure shows the complex
interrelationships between aging, cancer, inflammation, and telomerase. It underscores the
importance of telomerase in maintaining cellular integrity and its potential role in mediating both
cancer risk and chronic inflammatory conditions. This visualization aids in understanding how these
biological processes are interconnected and highlights the significance of telomerase as a
therapeutic target in addressing age-related diseases and cancer.
References
1. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol
Rev. 1997;61(3):377-92.
2. Hooper DC. Mechanisms of quinolone resistance. Clin Infect Dis. 2001;32(Suppl 1):S9-15.
3. Pan XS, Fisher LM. Targeting the GyrB subunit: insights into the mechanism of action of
aminocoumarins and novel inhibitors. Biochem Soc Trans. 2006;34(Pt 4):761-4.
4. Collin F, Karkare S, Maxwell A. Exploiting bacterial DNA gyrase as a drug target: current state
and perspectives. Appl Microbiol Biotechnol. 2011;92(3):479-97.
5. Triggle DJ, Triggle CR. Drug development for antimicrobial resistance: the way forward.
Pathogens. 2020;9(6):465.
6. Bax BD, Murshudov G, Maxwell A, Germe T. Structural and biochemical characterization of a
novel DNA gyrase inhibitor. Nucleic Acids Res. 2019;47(16):10168-80.
7. Ruiz J. Mechanisms of resistance to quinolones: target alterations, decreased accumulation,
and DNA repair. J Antimicrob Chemother. 2003;51(5):1109-17.
8. Morais Cabral JH, Jackson AP, Smith CV, Shikotra N, Maxwell A, Liddington RC. Crystal
structure of the breakage-reunion domain of DNA gyrase. Nature. 1997;388(6645):903-6.
9. Mitchenall LA, Peng H, Trinick MJ, Yan J, Maxwell A. DNA gyrase complex with DNA reveals
a gate-DNA wrap as the basis for DNA supercoiling and decatenation. Elife. 2021;10:e67273.
10. Blower TR, Williamson BH, Kerns RJ, Berger JM. Crystal structure and stability of gyrase-
fluoroquinolone cleaved complexes from Mycobacterium tuberculosis. Proc Natl Acad Sci U S
A. 2016;113(7):1706-13.
11. Bush NG, Evans-Roberts K, Maxwell A. DNA topoisomerases. EcoSal Plus.
2015;6(2):10.1128/ecosalplus.ESP-0010-2014.
12. Hiasa H, Yousef DO, Marians KJ. DNA strand cleavage is required for replication fork arrest
by a frozen topoisomerase-quinolone-DNA ternary complex. J Biol Chem.
1996;271(42):26424-9.
13. Champoux JJ. DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem.
2001;70:369-413.
14. Kumar S, Singh M, Singh SK. Targeting DNA gyrase: challenges and future perspectives. Med
Res Rev. 2021;41(1):401-31.
15. Chan PF, Germe T, Bax BD, et al. Structural insights into the mechanism of inhibition of DNA
gyrase by an antibacterial synthetic DNA mimic. Proc Natl Acad Sci U S A.
2017;114(24):E4991-500.
16. Shen LL, Pernet AG. Mechanism of inhibition of DNA gyrase by quinolone antibacterials: a
cooperative drug-DNA binding model. Biochemistry. 1985;24(3):485-92.
17. Kerns RJ, Blower TR, Berger JM. Allosteric modulation of DNA gyrase: implications for
targeting multidrug-resistant bacteria. ACS Infect Dis. 2018;4(1):107-15.
18. Correia S, Poeta P, Hebraud M, Capelo JL, Igrejas G. Mechanisms of quinolone action and
resistance: where do we stand? J Med Microbiol. 2017;66(5):551-9.
19. Gao R, Zhang R, Zhang Q. The emerging role of DNA gyrase in antibiotic resistance. J Mol
Med. 2019;97(9):1307-15.
20. Malik M, Chan N, Graves D, Drlica K. Mechanisms of fluoroquinolone killing. Antimicrob
Agents Chemother. 2006;50(3):949-56.
21. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Molecular Biology of the Cell. 6th
ed. Garland Science; 2014.
22. Cox MM, Doudna JA, O'Donnell M. Molecular Biology: Principles and Practice. 2nd ed.
Macmillan Learning; 2015.
23. Madigan MT, Bender KS, Buckley DH, Sattley WM, Stahl DA. Brock Biology of
Microorganisms. 15th ed. Pearson; 2018.
24. Lewin B, Cassimeris L, Helms C, et al. Lewin’s Genes XII. 12th ed. Jones & Bartlett Learning;
2018.
25. Watson JD, Baker TA, Bell SP, Gann A, Levine M, Losick R. Molecular Biology of the Gene.
7th ed. Pearson; 2013.